RCEL Stock Summary and Trading Ideas (Avita Medical | NASDAQ:RCEL)

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

What symbol and exchange does Avita Medical shares trade?

Avita Medical trades on the NASDAQ stock market under the symbol RCEL.

What is Avita Medical stock price doing today?

As of February 24, 2026, RCEL stock price climbed to $5.39 with 712,040 million shares trading.

What is Avita Medical's Beta?

RCEL has a beta of 0.94, meaning it tends to be less sensitive to market movements. RCEL has a correlation of 0.04 to the broad based SPY ETF.

How much is Avita Medical worth?

RCEL has a market cap of $165.11 million. This is considered a Micro Cap stock.

How much money does Avita Medical make?

Last quarter Avita Medical reported $18 million in Revenue and -$.38 earnings per share. This fell short of revenue expectation by $-8 million and exceeded earnings estimates by $.09.

What is the highest and lowest price Avita Medical traded in the last 3 year period?

In the last 3 years, RCEL traded as high as $21.70 and as low as $3.22.

What are the top ETFs holding Avita Medical?

The top ETF exchange traded funds that RCEL belongs to (by Net Assets): VTI, VXF, IWM, IWO, VTWO.

Is Avita Medical (RCEL) a good investment?

RCEL has underperformed the market in the last year with a return of -44.7%, while SPY returned +15.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RCEL shares. However, RCEL has outperformed the market in the last 3 month and 2 week periods, returning +42.2% and +33.1%, while SPY returned +4.6% and -1.0%, respectively. This indicates RCEL has been having a stronger performance recently.

What are the support and resistance levels for Avita Medical (RCEL)?

RCEL support price is $4.61 and resistance is $5.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RCEL shares will trade within this expected range on the day.